Sure, yes. Well, actually, Fells performed extremely well. So it's really – we have a group of customers, it still is a very small portion of our business, but it's big enough to move that needle, that buy particular products. And when the market – sometimes you can get upside down or – you have to carry inventory in the protein business. So it depends on some of those contracts. And it's still a small part of our business, but it's big enough – we're still small enough that it can affect the margins as it did the first quarter. And again, being such the slowest quarter of the year, our weakest quarter, has a larger effect. You saw that we tightened up our guidance, so we're pretty confident in our forecast and our ability to execute to the yearly forecast. So it's not something I'm terribly worried about. Second quarter already, we saw a little bit more of a – we saw some relief in those particular categories. But as Chef grows, really, our goal is to grow protein to look more like our specialty business. And that's really done by bigger mix of customers, so lots of smaller customers who buy a little bit of everything from Chefs'. So that kind of starts to mitigate that kind of risk with concentration, and basically having a tighter regional management team, which is really our focus, giving more of the responsibility regionally, though we look at it – we try to buy the big products centrally, but giving the regional managers control to be able to protect margin. But when you get a quarter like the first quarter, where you have rapid inflation sometimes of $1, $2 a pound an item, you really start to look at more protecting your gross profit dollars, Kelly, because your basic overhead is not increasing. So it's not costing you more to really move that box, so really, it becomes more protecting the gross profit dollars. And that, I think, that we're getting better and better at. But the pricing teams are really getting to focus on protein now. We've been talking about our pricing teams the last few years, and you can see the benefits with specialty margins really performing. And we think we can take that focus and that metric ability to measure and kind of pass it through to the selling teams. We think that we'll just get better and better in managing margin in protein.